Prediction of individualized lifetime benefit from cholesterol lowering, blood pressure lowering, antithrombotic therapy, and smoking cessation in apparently healthy people. (2020)
Attributed to:
Aetiology of type 2 diabetes and related metabolic disorders
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.17863/cam.42441
Publication URI: https://www.repository.cam.ac.uk/handle/1810/295386
Type: Journal Article/Review